Closed
SectorHealthcare
37.18 1.28
24h
Min
36.68
Max
37.39
Income | -18M -151M |
---|---|
Sales | -26M 139M |
EPS | -1.57 |
Profit margin | -108.463 |
Employees | 1,294 |
EBITDA | -18M -126M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +136.46% upside |
Next Earnings | 31 lip 2025 |
---|
Market Cap | -209M 3.4B |
---|---|
Previous open | 35.9 |
Previous close | 37.18 |
By Acuity
50%
50%
166 / 380 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 87.87 USD 136.46%
High 136 USD
Low 39 USD
Based on 15 Wall Street analysts offering 12 month price targets forUltragenyx Pharmaceutical Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$